---
schema_version: "secwatch.filing_event.v1"
accession: "0001193805-23-000700"
form_type: "8-K"
ticker: "IMUX"
cik: "0001280776"
company_name: "IMMUNIC, INC."
filed_at: "2023-05-11T23:59:59+00:00"
generated_at: "2026-06-15T03:40:52.723944+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Immunic Q1 net loss $25.3M; positive phase 1b IMU-856 celiac data; cash $97.1M

## Summary
- Q1 net loss $25.3M ($0.58/sh) vs $20.8M ($0.74/sh); R&D expenses $23.0M up from $17.4M YoY.
- Cash, equivalents and investments $97.1M as of Mar 31, 2023; expected to fund operations into Q4 2024.
- Positive phase 1b IMU-856 celiac data: proof-of-concept with improvements in histology, symptoms, biomarkers, nutrient absorption.
- Interim results from phase 2 CALLIPER trial of vidofludimus calcium in progressive MS expected H2 2023.
- Richard Rudick, M.D. added to board Apr 26, 2023; Vincent Ossipow, Ph.D. to step down June 28, 2023.

## SEC filing metadata
- accession: 0001193805-23-000700
- form_type: 8-K
- ticker: IMUX
- cik: 0001280776
- company_name: IMMUNIC, INC.
- filed_at: 2023-05-11T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1280776/000119380523000700/0001193805-23-000700-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1280776/000119380523000700/e618615_8k-immunic.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193805-23-000700
- JSON: https://secwatch.observer/filing/0001193805-23-000700.json
- Plain text: https://secwatch.observer/filing/0001193805-23-000700.txt

## Key facts
- Earnings Releases
  IMMUNIC, INC. reported financial results for first quarter ended March 31, 2023.
  - Period: first quarter ended March 31, 2023
  - Result: reported results
  source text: On May 11, 2023, Immunic, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2023 and providing a corporate update (the “Press Release”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1280776/000119380523000700/0001193805-23-000700-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.